Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral labetalol versus oral nifedipine for postpartum hypertension control in Enugu
PACTR202503593160636Not yet recruiting
- Sponsor
- self
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in hypertension (HTN) comparing Oral labetalol with Oral nifedipine (2 arms). Primary endpoint: Average time interval to sustained blood pressure control. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
labetalolnifedipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on PACTR202503593160636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503593160636.